Go to deals
Consumer & Retail

SwissEdilab has sold the brands Colon Pure & Ail Noir Oxyprotect to Noreva Pharma

SwissEdilab, a firm specialized in distribution of food supplements, has sold the brands Colon Pure and Ail Noir Oxyprotect to Noreva Pharma.

Noreva Pharma is a French cosmetics laboratory specialized in the development of dermatological care products distributed in drug stores.
This strategic acquisition expands the firm's product range distributed by its sales force. Noreva Pharma, which is very active in the OTC health market in France, had already acquired Phythea in 2016 and the Bergasol brand from Omega Pharma in 2018.

Oaklins' team in France was the sell-side advisor for SwissEdilab in this transaction.

Parties

Talk to the deal team

Ludovic Beaulieu

Partner
Paris, France
Oaklins France

Related deals

Venus Wine & Spirit Merchants plc has been acquired by Booker Group Ltd., a subsidiary of Tesco plc
Consumer & Retail | Food & Beverage

Venus Wine & Spirit Merchants plc has been acquired by Booker Group Ltd., a subsidiary of Tesco plc

The shareholders of Venus Wine & Spirit Merchants plc have sold the company to Booker Group Ltd., a subsidiary of Tesco plc. The move allows the Tesco subsidiary to bolster its on-trade portfolio through the addition of Venus’ range of over 2,000 spirits, beers, wines and soft drinks.

Learn more
Kees Smit Tuinmeubelen has been acquired by Craft Capital
Private Equity | Consumer & Retail

Kees Smit Tuinmeubelen has been acquired by Craft Capital

Kees Smit Tuinmeubelen, a leading family-owned omnichannel retailer of garden furniture and related accessories, has agreed to sell a majority stake to Craft Capital, a Netherlands-based investment firm. The transaction is still subject to fulfillment of customary closing conditions.

Learn more
Mobeus has acquired Distant Journeys
Private Equity | Consumer & Retail

Mobeus has acquired Distant Journeys

Mobeus Equity Partners has acquired Distant Journeys. Mobeus will support co-founder and MD, Simon Whittle. With the new funding, Distant Journeys plans to enhance its offerings in established markets and aims to extend its reach with expansion into new destinations.

Learn more